Back to results
US 2025/0207202 A1Published application
Methods and compositions for identifying hox gene signatures to assign specific and effective therapies in acute myeloid leukemia and other cancers
AssigneeOhio State Innovation Foundation
InventorsChristopher OAKES, James BLACHLY, John BYRD
Life of this patent
Estimating the term…
Abstract
The present disclosure provides kits and/or methods of detecting and identifying epigenetic patterns associated with acute myeloid leukemia and other cancers. The present disclosure also relates to treating, preventing, ameliorating, or reducing acute myeloid leukemia and other cancers.
Claims21
A method of treating a subject with cancer, the method comprising:
- a) obtaining a tissue sample from the subject;
- b) extracting a nucleic acid from the tissue sample;
- c) analyzing an epigenetic pattern of the nucleic acid;
- d) comparing the epigenetic pattern from the subject to a control panel;
- e) categorizing the subject into an epitype selected from epitype 1, epitype 2, epitype 3, epitype 4, epitype 5, epitype 6, epitype 7, epitype 8, epitype 9, epitype 10, epitype 11, epitype 12, or epitype 13 based on the epigenetic pattern;
- and
- f) administering a treatment to the subject according to the at least one epitype.
4 more elements
The method of 11, wherein the TF-SC comprises epitype 1, epitype 2, epitype 3, or epitype 4.
21-32. (canceled)
Dependencies are inferred from the claim text.